Alexander Stark

Alexander Stark
Alma mater
Scientific career
Fields gene expression in development, transcription
Institutions
Doctoral advisor Robert B. Russell
Website www.imp.ac.at/groups/alexander-stark/

Alexander Stark (born 1974) is a biochemist and computational biologist working on the regulation of gene expression in development.[1] He is a senior scientist at the Research Institute of Molecular Pathology (IMP) at the Vienna Biocenter and adjunct professor of the Medical University of Vienna.

Early life and education

Alexander Stark grew up in Baden-Württemberg, Germany. He studied biochemistry at the University of Tübingen, and graduated with a diploma in biochemistry in 2000. In 2001, he started to do research for doctoral studies in the group of Robert B. (Rob) Russell at the European Molecular Biology Laboratory (EMBL) and obtained his doctorate from the University of Cologne in 2004. Stark remained at EMBL for one more year as a bridging postdoc.

Career

In 2005, Stark became a postdoctoral researcher in the groups of Eric S. Lander and Manolis Kellis at the Broad Institute of MIT and Harvard University and the MIT Computer Science and Artificial Intelligence Laboratory (CSAIL) in Boston, USA. His postdoctoral research was supported by EMBO, HFSP, and the Schering Foundation.

In 2008, Stark became group leader[2] at the Research Institute of Molecular Pathology (IMP) in Vienna and was promoted to senior scientist in 2015.[3] He was made adjunct professor of the Medical University of Vienna in 2017.

Research

Alexander Stark studies the regulation of gene expression in response to developmental or environmental stimuli to learn how transcription and transcriptional networks define cellular and developmental programs.[4][1]

More specifically, he investigates how transcription is regulated at the level of enhancer and core-promoter DNA elements, and the transcription factor and cofactor proteins that mediate transcription activation. He uses genome-wide functional assays, bioinformatics, and mass spectrometry, and develops innovative reporter assays (such as STARR-seq) that provide direct functional readouts.[1]

Awards and achievements

Alexander Stark was selected EMBO Young Investigator in 2012;[5] announced as "highly cited researcher" by Thomson Reuters in 2014[6] and elected member of EMBO in 2015.[7][8]

Among other grants and fellowships, Stark was awarded a starting grant of the European Research Council (ERC) in 2009, and a consolidator grant of the ERC in 2015.[9] He is on the editorial boards of Genes & Development[10] and Molecular Systems Biology.[11]

References

  1. 1 2 3 "Alexander Stark - Systems biology of regulatory motifs & networks". The Research Institute of Molecular Pathology. Retrieved 2018-02-11.
  2. ↑ https://www.imp.ac.at/fileadmin/content/About_IMP/Research_Reports/2008_IMP_Research_Report.pdf
  3. ↑ https://www.imp.ac.at/fileadmin/content/IMP_ResearchReport.pdf
  4. ↑ "Deciphering the transcriptional cis-regulatory code". Stark Lab. 2018-02-05. Retrieved 2018-02-11.
  5. ↑ "Find a Young Investigator". EMBO.
  6. ↑ Pathology, The Research Institute of Molecular. "Alexander Stark among the world's most highly cited researchers".
  7. ↑ Pathology, The Research Institute of Molecular. "Press Release: EMBO Accolade for Alexander Stark".
  8. ↑ "Find a Member". EMBO.
  9. ↑ "IMP Scientist Alex Stark awarded an ERC Consolidator Grant". idw-online.de.
  10. ↑ "Genes & Development -- About the Journal". genesdev.cshlp.org.
  11. ↑ "Editors & Board - Molecular Systems Biology". msb.embopress.org.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.